OXYFLUNIZER is an injection primarily used for treating bovine respiratory disease associated with Mannheimia haemolytica, offering anti-inflammatory and anti-pyretic effects.
OXYFLUNIZER is a treatment injection aimed at bovine respiratory disease related to Mannheimia haemolytica. It provides anti-inflammatory and anti-pyretic effects and is effective against various organisms sensitive to oxytetracycline in vitro.
OXYFLUNIZER is indicated for bovine respiratory disease linked to Mannheimia haemolytica, necessitating anti-inflammatory and anti-pyretic action. It’s effective against oxytetracycline-sensitive organisms like Pasteurella spp., Arcanobacterium pyogenes, Staphylococcus aureus, and certain mycoplasmas.
Each 1 ml contains
For deep intramuscular injection to cattle.
The recommended dosage is 1ml per 10kg bodyweight (equivalent to 30mg/kg oxytetracycline and 2mg/kg flunixin meglumine) on a single occasion. Maximum volume per injection site: 15ml. If concurrent treatment is administered, use a separate injection site.